Atlas Venture Fund X, L.P.'s Form 4 filing
Disc Medicine, Inc. (IRON) · filed Dec 14, 2023
- Accession no.
- 0001209191-23-058707
- Filed
- Dec 14, 2023, 8:13 PM ET
- Trade date
- Dec 12-14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 22 non-derivative transactions. Open-market sales total $11.7M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Atlas Venture Fund X, L.P.CIK 0001628098 | 10% Owner |
| Atlas Venture Associates X, LLCCIK 0001742765 | 10% Owner |
| Atlas Venture Associates X, L.P.CIK 0001742766 | 10% Owner |
| Atlas Venture Opportunity Fund I, L.P.CIK 0001759241 | 10% Owner |
| Atlas Venture Associates Opportunity I, L.P.CIK 0001780065 | 10% Owner |
| Atlas Venture Associates Opportunity I, LLCCIK 0001780066 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2023 | Common Stock | SSaleDisposed | −31,235 | $59.87F1 | −$1,870,039.45 | 1,562,550 | Direct | |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −20,823 | $59.87F1 | −$1,246,673.01 | 861,401 | Indirect | Duplicate filing |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −632 | $60.99F4 | −$38,545.68 | 1,561,918 | Direct | |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −422 | $60.99F4 | −$25,737.78 | 860,979 | Indirect | Duplicate filing |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −6,234 | $62.42F5 | −$389,126.28 | 1,555,684 | Direct | |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −4,155 | $62.42F5 | −$259,355.1 | 856,824 | Indirect | Duplicate filing |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −994 | $62.90F6 | −$62,522.6 | 1,554,690 | Direct | |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −665 | $62.90F6 | −$41,828.5 | 856,159 | Indirect | Duplicate filing |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −1,031 | $63.78F7 | −$65,757.18 | 1,553,659 | Direct | |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −688 | $63.78F7 | −$43,880.64 | 855,471 | Indirect | Duplicate filing |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −27,924 | $65.10F8 | −$1,817,852.4 | 1,525,735 | Direct | |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −18,615 | $65.10F8 | −$1,211,836.5 | 836,856 | Indirect | Duplicate filing |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −9,901 | $65.77F9 | −$651,188.77 | 1,515,834 | Direct | |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −6,599 | $65.77F9 | −$434,016.23 | 830,257 | Indirect | Duplicate filing |
| Dec 13, 2023 | Common Stock | SSaleDisposed | −5,263 | $59.99F10 | −$315,727.37 | 1,510,571 | Direct | |
| Dec 13, 2023 | Common Stock | SSaleDisposed | −3,508 | $59.99F10 | −$210,444.92 | 826,749 | Indirect | Duplicate filing |
| Dec 13, 2023 | Common Stock | SSaleDisposed | −60 | $60.50 | −$3,630 | 1,510,511 | Direct | |
| Dec 13, 2023 | Common Stock | SSaleDisposed | −40 | $60.50 | −$2,420 | 826,709 | Indirect | Duplicate filing |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −30,645 | $58.27F11 | −$1,785,684.15 | 1,479,866 | Direct | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −20,429 | $58.27F11 | −$1,190,397.83 | 806,280 | Indirect | Duplicate filing |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −180 | $59.74F12 | −$10,753.2 | 1,479,686 | Direct | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −120 | $59.74F12 | −$7,168.8 | 806,160 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.50 to $60.497 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (4), (5), (6), (7), (8), (9), (10), (11) and (12).
Referenced by the price of 2 transactions in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.51 to $61.50 inclusive.
Referenced by the price of 2 transactions in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.5297 to $62.5175 inclusive.
Referenced by the price of 2 transactions in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.6436 to $63.3256 inclusive.
Referenced by the price of 2 transactions in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.70 to $64.67 inclusive.
Referenced by the price of 2 transactions in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.7499 to $65.735 inclusive.
Referenced by the price of 2 transactions in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.745 to $66.32 inclusive.
Referenced by the price of 2 transactions in Table I.
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.50 to $60.4381 inclusive.
Referenced by the price of 2 transactions in Table I.
- F11
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.25 to $58.65 inclusive.
Referenced by the price of 2 transactions in Table I.
- F12
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.53 to $60.17 inclusive.
Referenced by the price of 2 transactions in Table I.